Kaitlyn D’Onofrio

DocwireNews

A new study identified predictors of patients most likely to experience <a href="https://www.docwirenews.com/cardiology/rivaroxaban-lowers-risk/">venous thromboembolic events (VTEs)</a> following rotator cuff repair (RCR) surgery.&ldquo;Venous thromboembolic events (<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/increased-risk-thromboembolic-events/">VTEs</a>) are a major source of morbidity and mortality, with an estimated 350,000-900,000 patients per year developing a deep venous thrombus (DVT) or <a href="https://www.docwirenews.com/cardiology/diagnose-prenatal-pulmonary-embolism/">pulmonary embolus</a> (PE),&rdquo; the study authors wrote. &ldquo;The incidence of symptomatic VTE for lower-extremity arthroplasty was found to be between 1.3% and 2.8%2, 3 and 1% and 1.8% in the setting of trauma even with prophylaxis using anticoagulation.&rdquo;Their findings were published in <a href="https://www.arthroscopyjournal.org/article/S0749-8063(19)30493-1/fulltext">Arthroscopy</a>.The researchers conducted a retrospective review of the American College of Surgeons National Surgical Quality Improvement Program database and used Current Procedural Terminology codes to find RCR patients treated from 2005 to 2017. The main outcomes were 30-day incidence of deep venous thrombosis (DVT) or pulmonary embolism (PE) after surgery. Patients with known VTE risk factors including age &gt; 90 years; underwent another operation 30 days prior to RCR; had disseminated cancer; were paralyzed, mentally altered, or unresponsive &gt; 24 hours; or had an infection at time of operation were excluded. Demographics collected included age, sex, smoking status during the year before admission, race, ethnicity, body mass index (BMI), and preoperative functional status.A total of 39,825 RCRs were performed during the study period; 117 (0.3%) VTEs were recorded. VTE presented at a mean 11.5 days. Most (n = 31,615) RCRs were performed arthroscopically; VTE rate did not largely differ between arthroscopic (0.3%, n = 93) versus open RCR (0.3%, n = 23). Patients with an American Society of Anesthesiologists (ASA) classification of III or IV had a greater VTE risk (odds ratio [OR] 1.68, 95% confidence interval [CI] 1.14-2.45); other risk factors included surgery &gt;80 minutes (OR 2.10, 95% CI 1.42-3.15), performed under general anesthesia (OR 4.38, 95% CI 1.18-36.6), and in the outpatient setting (OR 6.09, 95% CI 1.06-243.7); male sex (OR 1.53, 95% CI 1.01-2.33), bleeding disorders (OR 2.87, 95% CI 1.17-7.05), or dyspnea (OR 1.51, 95% CI 1.02-2.23). Unplanned reoperation was the most significant risk factor (OR 16.6, 95% CI 5.13-53.5).The researchers concluded that VTE after RCR is a rare complication but suggested that the risk factors be taken into consideration when treating patients.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

VTE Risk Factors After Rotator Cuff Repair

A new study identified predictors of patients most likely to experience venous thromboembolic events (VTEs) following rotator cuff repair (RCR) surgery.
 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe